These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8214364)

  • 1. Acute myocardial infarction complicating prothrombin complex concentrate therapy in an 8-year-old boy with hemophilia A and factor VIII inhibitor.
    Karayalcin G; Goldberg B; Cherrick I; Kurer C; Bierman F; Lanzkowsky P
    Am J Pediatr Hematol Oncol; 1993 Nov; 15(4):416-9. PubMed ID: 8214364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute myocardial infarction during treatment with an activated prothrombin complex concentrate in a patient with factor VIII deficiency and a factor VIII inhibitor.
    Chavin SI; Siegel DM; Rocco TA; Olson JP
    Am J Med; 1988 Aug; 85(2):245-9. PubMed ID: 3135752
    [No Abstract]   [Full Text] [Related]  

  • 3. Fatal myocardial infarction following therapy with prothrombin complex concentrates in a young man with hemophilia A.
    Sullivan DW; Purdy LJ; Billingham M; Glader BE
    Pediatrics; 1984 Aug; 74(2):279-81. PubMed ID: 6431390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance imaging of myocardial infarction during prothrombin complex concentrate therapy of hemophilia A.
    Gruen DR; Winchester PH; Brill PW; Ramirez E
    Pediatr Radiol; 1997 Mar; 27(3):271-2. PubMed ID: 9126591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial infarction after factor IX therapy.
    Fuerth JH; Mahrer P
    JAMA; 1981 Apr; 245(14):1455-6. PubMed ID: 6782256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Outcome of hemorrhage treatment in children with hemophilia A related to factor VIII inhibitor].
    Klukowska A; Zieleniewska B
    Acta Haematol Pol; 1994; 25(4):349-54. PubMed ID: 7847036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated prothrombin complex concentrate (FEIBA) treatment during surgery in patients with inhibitors to FVIII/IX: the updated Norwegian experience.
    Tjønnfjord GE
    Haemophilia; 2004 Sep; 10 Suppl 2():41-5. PubMed ID: 15385045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant VIIa concentrate in the management of bleeding following prothrombin complex concentrate-related myocardial infarction in patients with haemophilia and inhibitors.
    Hough RE; Hampton KK; Preston FE; Channer KS; West J; Makris M
    Br J Haematol; 2000 Dec; 111(3):974-9. PubMed ID: 11122162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The treatment of haemophilia A inhibitor with high dose intravenous immunoglobulin.
    Seifried E; Gaedicke G; Pindur G; Rasche H
    Blut; 1984 Jun; 48(6):397-401. PubMed ID: 6430366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial infarction complicating activated prothrombin complex concentrate substitution in patient with hemophilia A.
    Schimpf K; Zeltsch C; Zeltsch P
    Lancet; 1982 Nov; 2(8306):1043. PubMed ID: 6127522
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term results of the treatment of children with factor VIII inhibitors with prothrombin-complex concentrates.
    Ekert H; Smibert E; Exton J
    Med J Aust; 1987 Sep; 147(5):230-3. PubMed ID: 3118153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of prothrombin-complex concentrates in hemophiliacs with antibodies to factor VIII: a multicenter therapeutic trial.
    Lusher JM; Shapiro SS; Palascak JE; Rao AV; Levine PH; Blatt PM
    N Engl J Med; 1980 Aug; 303(8):421-5. PubMed ID: 6771653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated prothrombin complex concentrates in the management of the hemophiliac with Factor VIII inhibitor: case report.
    Griffen AL; Hoots WK; Carter AB
    Pediatr Dent; 1987 Dec; 9(4):321-4. PubMed ID: 3148907
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of factor VIII and prothrombin complex concentrates in the treatment of inhibitor patients.
    Prentice CR
    Prog Clin Biol Res; 1984; 150():197-206. PubMed ID: 6431428
    [No Abstract]   [Full Text] [Related]  

  • 15. Activated prothrombin concentrate for patients with factor VIII inhibitors.
    Kurczynski EM; Penner JA
    N Engl J Med; 1974 Jul; 291(4):164-7. PubMed ID: 4834485
    [No Abstract]   [Full Text] [Related]  

  • 16. Myocardial infarction after FEIBA therapy in a hemophilia-B patient with a factor IX inhibitor.
    Mizon P; Goudemand J; Jude B; Marey A
    Ann Hematol; 1992 Jun; 64(6):309-11. PubMed ID: 1637888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemophiliacs with inhibitors: therapeutic options.
    Roberts HR
    N Engl J Med; 1981 Sep; 305(13):757-8. PubMed ID: 6790992
    [No Abstract]   [Full Text] [Related]  

  • 18. [Postpartum hemophilia A with factor VIII inhibitor].
    Neidhardt B; Bartels O; Hahn B
    Dtsch Med Wochenschr; 1985 May; 110(20):799-802. PubMed ID: 3922727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prothrombin complex concentrates and inhibitors. A reappraisal.
    Kasper CK
    JAMA; 1984 Jan; 251(1):68-9. PubMed ID: 6418899
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of non-activated prothrombin complex concentrate (Proplex ST) on intraperitoneal hematoma in a hemophilia A patient with a factor VIII inhibitor.
    Kagawa H; Yasuzawa M; Ozaki Y; Yamamoto Y; Katsurada T; Nomura S; Okubo S; Fukuhara S
    Intern Med; 1996 Apr; 35(4):319-22. PubMed ID: 8739790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.